Fall 2016 Cycle Target Advancement Program

The Target Advancement program seeks to build robust evidence to rationalize biological pathways and targets for further translation into new Parkinson's treatments.

Target Validation
 research characterizing promising, novel PD-relevant targets 

Funding: $100,000

Duration: 1 year

Target Optimization 
 research into promising treatments within MJFF-defined priority biological pathways. For the Fall 2016 round, we invite projects designed to probe the therapeutic potential of targeting mechanisms of dystonia associated with PD.

Funding: $200,000 total 

Duration: 2 years 

Pre proposal (required) due date: 18.5.16

Full application due date: 5.8.16